{
  "actions": [
    {
      "acted_at": "2014-06-19", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4918-113", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": "13", 
      "name": "Ryan, Tim", 
      "sponsored_at": "2014-06-19", 
      "state": "OH", 
      "thomas_id": "01756", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2014-06-19", 
  "number": "4918", 
  "official_title": "To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Speeding Access to Already Approved Pharmaceuticals Act of 2014", 
  "sponsor": {
    "district": "15", 
    "name": "Stivers, Steve", 
    "state": "OH", 
    "thomas_id": "02047", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2014-06-19", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Europe", 
    "European Union", 
    "Food and Drug Administration (FDA)", 
    "Health", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2014-06-19", 
    "text": "Speeding Access to Already Approved Pharmaceuticals Act of 2014 - Amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA), under procedures for expedited approval of products to treat a serious or life-threatening disease or condition, to facilitate the development and expedite the review of new drugs or devices approved for marketing in the European Union."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Speeding Access to Already Approved Pharmaceuticals Act of 2014", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.", 
      "type": "official"
    }
  ], 
  "updated_at": "2015-09-01T10:20:46-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d113:HR4918:@@@L&summ2=m&"
}